EARLY AND MID-CAREER DEVELOPMENT OPPORTUNITIES JACQUELINE LLOYD, MSW, PHD NIH SUMMER INSTITUTE JULY 2012 NIIDA NATIONAL INSTITUTE ON DRUG ABUSE.

Slides:

Advertisements

Similar presentations

NIH K-22 Application Career Transition Award

Advertisements

Community-Based Participatory Research (CBPR) at NIH

TM NCI’s Smoking Cessation Activities and Priorities: Discovery, Development and Delivery Scott J. Leischow, Ph.D. National Cancer Institute.

1 1 Opportunities for Integrating Substance Use Disorder Treatment into Care Coordination Processes Darren Urada, Ph.D. UCLA Integrated Substance Abuse.

Overview Background information on AREA program Applying for an AREA grant Funding for the AREA program Updates to the program Strategies for successfully.

What’s NIH? National Cancer Institute National Eye Institute National Heart, Lung, and Blood Inst. National Human Genome Research Inst National Institute.

Promoting Diversity and Science for Health Equity -- Introduction of NIDA Minority Diversity Programs Yu (Woody) Lin, M.D., Ph.D Program Director Division.

The CDC Prevention Grant Funding Opportunity Announcement (FOA) and OA’s Response Overview and Discussion September 21, 2011 California Department of Public.

Cheryl Anne Boyce, Ph.D. National Institute on Drug Abuse Roger G. Sorensen, Ph.D., MPA National Institute on Drug Abuse 2010 NIH Regional Seminars, Portland.

Decoding RFAs and PAs Charlotte FlippDivision of Epidemiology & Community Health (EpiCH) Anne EverettDivision of Epidemiology & Community Health (EpiCH)

Methodology for Adaptive Treatment Strategies R21 DA S.A. Murphy For MCATS Oct. 8, 2009.

Career Development in Translational Addiction Research

Leo Rennie, MPA Senior Legislative & Federal Affairs Officer Federal AIDS Policy Partnership Meeting September 10, 2014 Washington, DC.

Roger Sorensen, Ph.D., MPA Program Official National Institute on Drug Abuse 1 Update on “New” Investigator Activities.

The Life Cycle of an NIH Grant Application Alicia Dombroski, Ph.D. Deputy Director Division of Extramural Activities NIDCR.

Mobile Technology Development and Dissemination at CTxCARES Deborah Vollmer Dahlke, MPAff Yan Hong, PhD October 16, 2012 This presentation was supported.

Public Health and Healthcare in Ontario A Made in Ontario Solution for Public Health and Healthcare Andrew Papadopoulos Director, School of Occupational.

Funding Priorities: National Cancer Institute Carly Parry, PhD, MSW National Cancer Institute.

Addiction Health Services Research Conference Lexington, KY Louise Haynes, MSW Adoption of HIV Counseling and Testing Following Completion of Randomized.

Nancy L Desmond, Ph.D. Division of Neuroscience & Basic Behavioral Science Key Things to Know about Research Project Grants (R01)

Division of AIDS, Behavioral and Population Sciences Risk, Prevention and Health Behavior IRG August, 2014 Reorganization/Realignment of RPHB Addictive.

Kathryn Camp, M.S., R.D., CSP Consultant to the Office of Dietary Supplements National Institutes of Health Secretary’s Advisory Committee on Heritable.

The 10 Key Components of Veteran’s Treatment Court Presented by: The Honorable Robert Russell.

Short Overview of the NIH SBIR/STTR Program “Lab to Life”

1 CRCHD-sponsored Professional Development and Mock Review Workshop June 23, 2014 NIH Funding Opportunities, Grant Applications, and Recent Changes Christopher.

Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 29 Writing Proposals to Generate Evidence.

TYPE 2 TRANSLATIONAL RESEARCH 2009 GRANT PROGRAMS UW Institute for Clinical and Translational Research (ICTR) Community-Academic Partnership Core (CAP)

National Health and Medical Research Council NHMRC – EU Collaborative Research Grants Scheme Dr Nick Johnson Research Programs Branch NHMRC.

Research Opportunities at the National Institutes of Health

Screening, Brief Intervention, Referral, and Treatment (SBIRT) Juli Harkins June 26, 2005 Division of Services Improvement Organization and Financing.

Science for Global Health: Fostering International Collaboration Norka Ruiz Bravo,PhD Special Advisor to the Director National Institutes of Health U.S.

Navigating the Changes to the NIH Application Instructions Navigating the Changes to the NIH Application Instructions EFFECTIVE JANUARY 25, 2010.

Mental Health and Substance Abuse Services Joe Vesowate Assistant Commissioner.

1 Promotoras, Peer Participant Providers and Community Outreach as Preconception in the Continuum of Perinatal HIV Transmission Armida Ayala, M.H.A., Ph.D.

Fogarty International Center: HIV Research Training Program: New Applications and Strategies Gene D. Morse, PharmD University at Buffalo AIDS International.

NIH U-01 Application Limited Competition: Women’s Interagency HIV Study (WIHS-V)

REPORT The National Advisory Council on Drug Abuse Work Group On NIDA’s Approach to Grant-Making May 2006 The National Institute on Drug Abuse.

FUTURE HIV RESEARCH EFFORTS PLANNED FOR THE CLINICAL TRIALS NETWORK James L. Sorensen, Ph.D. Susan Tross, Ph.D. Raul Mandler, M.D. University of California,

Implementation Science and the Adoption of Practice in Addiction Treatment Harold I Perl, PhD Center for the Clinical Trials Network National Institute.

Overview of NIDA Funding Opportunities and Grant Funding Tips Bethany Griffin Deeds, Ph.D., M.A. Deputy Chief, Epidemiology Research Branch Division of.

Funding HIV/AIDS Research in the Current Environment Celeste Watkins-Hayes, Ph.D. Northwestern University 2009 NSF CAREER Award Recipient 2008 RWJ Health.

Specific Aims  Modify a previously used ACASI (audio computer assisted structured interview) assessment tool, the Sexual Behavior Inventory (SBI), for.

NIDA Portfolio on Performance and Outcome Research Sarah Duffy Using Performance Measures and Outcomes to Improve Treatment Sheraton Gateway Hotel, Los.

Treatment is the Key: Addressing Drug Abuse in Criminal Justice Settings Redonna K. Chandler, Ph.D. Branch Chief Services Research Branch Division of Epidemiology,

The Minority AIDS Initiative (MAI): Then and Now Edwin M. Craft, Dr. P

Gustavo Aquino, MPH Associate Director for Program Integration National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention Program Collaboration.

The Pathways to Research Funding at the National Institute on Alcoholism and Alcohol Abuse Judith A. Arroyo, Ph.D. Division of Epidemiology and Prevention.

AHRQ 2011 Annual Conference: Insights from the AHRQ Peer Review Process Training Grant Review Perspective Denise G. Tate Ph.D., Professor, Chair HCRT Study.

Cathy Worthem, MSW Joyce Washburn, MPA BFSS, May 2011 Phoenix, AZ.

State of California Department of Alcohol and Drug Programs State Incentive Grant Project Overview Michael Cunningham Deputy Director, Program Services.

New Investigator and Early Career Grant Opportunities Dan Hoyt.

A National Listing: Alcohol, Tobacco & Other Drugs Knowledge Development & Application Grant Awards Compiled by the ATTC National Office The Addiction.

The Importance of a Strategic Plan to Eliminate Health Disparities 2008 eHealth Conference June 9, 2008 Yvonne T. Maddox, PhD Deputy Director Eunice Kennedy.

Services Research & the CTN: We keep getting better! Redonna K. Chandler, Ph.D. Chief, Services Research Branch Division of Epidemiology, Services and.

Why Write A Grant? Elaine M. Hylek, MD, MPH Professor of Medicine Associate Director, Education and Training Division BU CTSI Section of General Internal.

Alcohol and AIDS: A New Decade Grantsmanship Workshop XIX International AIDS Conference Rome, Italy Kendall J. Bryant, Ph.D., NIAAA Alcohol and AIDS Research.

Nanotechnology involves the creation and use of materials and devices at the level of molecules and atoms. Nanomedicine, an offshoot of nanotechnology,

Update from the Division of Epidemiology, Services and Prevention Research Wilson M. Compton, M.D., M.P.E. Director, Division of Epidemiology, Services.

Barnstable County Regional Substance Abuse Council Updated October 2015 Barnstable County Department of Human Services |

Accelerating Progress Towards a More Diverse and Inclusive Harvard Chan School April 17, 2015.

Social Accountability for RMNCAH Shout Out for Health A global competition to generate public demand for the health and well-being of women, children and.

R01? R03? R21? How to choose the right funding mechanism Thomas Mitchell, MPH Department of Epidemiology & Biostatistics University of California San Francisco.

David M. Murray, Ph.D. Associate Director for Prevention Director, Office of Disease Prevention Multilevel Intervention Research Methodology September.

Science for Global Health: Fostering International Research Collaboration James Herrington, PhD, MPH Director Division of International Relations Fogarty.

Lorenzo Refolo & M-D Kerns

NIH Fellowships Overview

Marie P. Bresnahan, MPH, Mary M

An Insider’s View: Writing Your Successful NIH Application

Community Engagement Subcommittee – Update

NIA-AABC May 9th, 2018 Webinar Lorenzo Refolo & Yuan Luo

Presentation transcript:

EARLY AND MID-CAREER DEVELOPMENT OPPORTUNITIES JACQUELINE LLOYD, MSW, PHD NIH SUMMER INSTITUTE JULY 2012 NIIDA NATIONAL INSTITUTE ON DRUG ABUSE

GOALS Share Information About NIDA’s Research Portfolio Share Current Funding Opportunities

From Molecules… NIDA RESEARCH … To Genetics … Behavioral Treatment … Drug Courts … Health Services Research

NIDA Priority Areas New Targets & New Strategies genetics/epigenetics development environment co-morbidity HIV/AIDS, HCV Prevention Treatment Interventions Medical Consequences

National Institute on Drug Abuse

Current Funding Opportunities FEATURES Duration: Up to 2+4 years Support : Up to $275K for 2 yrs + Up to $1.5M for 4 years; no > 5 yrs Renew : No Pages : 12 pages PO: Sarah Duffy AIDS-Science Track Award for Research Transition – A-START (R03; PA ) Expires: September 8, 2012 FEATURES Duration: 2 years Support : $100K per yr Renew: No Pages : 6 pages PO: Richard Jenkins Phased Services Research Studies of Drug Use Prevention, Addiction Treatment, and HIV in an Era of Health Care Reform (R21/R33; RFA-DA ) Expires: August 23, 2012

Current Funding Opportunities Accelerating Pace of Drug Abuse Research Using Existing Epidemiology, Prevention & Treatment (R01; PAR ) Expires January 8, 2013 FEATURES Duration - 3 years Support : Up to $450K Renew : Yes; Pages: 12 $2M to fund 5-8 grants PO: Marsha Lopez Drug Abuse Prevention Intervention Research (R01, R21, R03; PA ) Expires: September 8, 2014 FEATURES: R01 R03 R21 Duration : 5 yrs 2 yrs 2 yrs Support:...$ $100K $275 Renew: Yes No No Pages: POC: Harold Perl

Current Funding Opportunities FEATURES Duration - 3 years Support : Up to $450K Renew: No Pages : 12 PO: Jacqueline Lloyd (NIDA) Judith Arroyo (NIAAA) FEATURES: Duration : 3 years Support: Up to $450K Renew: No Pages: 12 Po: Rich Jenkins, Shoshana Kahana, Will Aklin Development and Testing of Novel Interventions to Improve HIV Prevention, Care, and Program Implementation (R34; PA ) Expires: May 8, 2015 Pilot and Feasibility Studies in Preparation for Drug Abuse Prevention Trials (R34; PA ) Expires: May 8, 2015

Current Funding Opportunities FEATURES: R01 R34 Duration : 5 yrs 3 yrs Support: avail of $ $450K Renew: Yes No Pages: PO: Shoshana Kahana, Will Aklin FEATURES: R01 R03 R21 Duration : 5 yrs 2 yrs 2 yrs Support:...$ $100K $275 Renew: Yes No No Pages: PO: Rich Jenkins, Dionne Jones, Will Alkin Drug Abuse Aspects of HIV/AIDS (R03, R21, R01; PA ) Expires: January 8, 2012 Technology-Based Interventions to Promote Engagement in Care and Treatment Adherence for Substance Abusing Populations with HIV (R01; R34; PA ) Expires: January 8, 2015

Current Funding Opportunities FEATURES Duration - 3 years Support : Up to $450K Renew : No Pages : 12 PO: Lori Ducharme (NIDA); Robert Huebner (NIAAA) Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Abuse (R34; PA ) Expires: May 8, 2015 Behavioral and Integrative Treatment Development Program (R01, R03, R34; PA ) Expires: January 8, 2013 FEATURES: R01 R03 R34 Duration : 5 yrs 2 yrs 3 yrs Support:...$ $100K $450 Renew: Yes No No Pages: PO: Lisa Onken, Daniel Falk, Jeanette Hosseini

NIH Parent Announcements R01 – Research Project Grant (Parent R01) - PA PA R23 - NIH Exploratory/Developmental Research Grant Program (Parent R21) - PA PA R03 - NIH Small Research Grant Program (Parent R03) - PA PA

Suggestions/Strategies Become familiar with Funding Opportunity Announcements – Identify appropriate/relevant Institutes. Develop a relationship with Project Officer in relevant Institute/Division. Get Program Officer feedback on concept paper. Communicate with Program Officer during concept/application development, prior to submission, after review. Become familiar with review committees. Develop/maintain relationships with strong mentors and collaborators.

Submit a Concept Paper Study Goals  You want support to do what? Problem/Significance  Why does this topic need study? Research Question  What hypotheses will you test? Design/Analysis  What study design and statistical approach do you propose? Team  Who will be the key participants and collaborators? A concept paper describes your research plans concisely. It’s a tool to facilitate productive discussion with an NIH Program Official. Suggest 1 page.

Good Luck!!! Jacqueline Lloyd National Institute on Drug Abuse Division of Epidemiology, Services and Prevention Research Prevention Research Branch